Virax Biolabs ratios data for the quarter ended Mar 2026. These financial ratios cover 10 quarters of results from Mar 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2021 | Mar2022 | Sep2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | ||||||||||
| Inventory AverageInventory Avg. | 0.02M | 0.04M | 0.09M | 0.11M | 0.07M | |||||
| Assets AverageAssets Avg. | 0.04M | 2.67M | 7.56M | 8.42M | 6.25M | 7.46M | 7.93M | 6.07M | 7.02M | |
| Equity AverageEquity Avg. | -1.01M | 1.60M | 6.65M | 7.62M | 5.74M | 6.89M | 4.38M | 2.71M | 2.50M | |
| Invested CapitalInvested Cap. | -0.83M | -1.19M | 4.78M | 9.05M | 8.87M | 0.14M | 5.51M | -0.28M | ||
| Leverage & Solvency | ||||||||||
| Debt Ratio | 0.09 | 0.08 | 0.07 | 0.01 | 0.02 | 0.01 | 0.03 | 0.00 | ||
| Valuation | ||||||||||
| Price to BookP/B | 1.83 | 0.83 | 0.55 | 0.28 | 0.45 | 44.07 | 0.50 | |||
| Enterprise Value | 3.23M | -2.19M | -1.88M | -2.38M | -3.62M | 0.49M | -0.94M | -4.49M | ||
| Market Capitalization | 8.03M | 7.39M | 3.45M | 1.44M | 3.89M | 4.95M | 2.64M | 2.19M |
Pull Virax Biolabs's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=VRAX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "VRAX", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=VRAX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();